Emergence of Severe and Prolonged Hepatobiliary Disorders Following COVID-19 Infection: A Systematic Analysis - Scorecard - MDSpire

Emergence of Severe and Prolonged Hepatobiliary Disorders Following COVID-19 Infection: A Systematic Analysis

  • By

  • Ali Aboulwafa

  • Ahamed Lebbe

  • Aya Khalil

  • Nuran Bayraktar

  • Beshr Mushannen

  • Sama Ayoub

  • Shaunak Sarker

  • Marwan Nour Abdalla

  • Sa’ad Laws

  • Ibrahim Mohammed

  • Lina Yagan

  • Malik Mushannen

  • Dalia Zakaria

  • February 4, 2026

  • 0 min

Share

Clinical Scorecard: Emergence of Severe and Prolonged Hepatobiliary Disorders Following COVID-19 Infection: A Systematic Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsDirect viral invasion, systemic inflammation, prolonged inflammation, immune dysregulation, and potential for liver fibrosis.
Target Population
Care Setting

Key Highlights

  • highlight_1

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of hepatobiliary injury should occur at least one month post-COVID-19 infection, with specific criteria outlined.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Management may include supportive care, monitoring for severe complications, and potential pharmacological interventions.

        Clinical Best Practices

        • practice_1

        References

        Original Source(s)

        Emergence of Severe and Prolonged Hepatobiliary Disorders Following COVID-19 Infection: A Systematic Analysis

        • by Ali Aboulwafa, Ahamed Lebbe, Aya Khalil, Nuran Bayraktar, Beshr Mushannen, Sama Ayoub, Shaunak Sarker, Marwan Nour Abdalla, Sa’ad Laws, Ibrahim Mohammed, Lina Yagan, Malik Mushannen, Dalia Zakaria

        • February 4, 2026

        Related Content

        COVID-19, Vaccines, and Retinal Vascular Disease

        A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.

        FDA Monthly Preview: Key June Decisions to Watch

        Several FDA decisions across multiple specialties are expected this month.

        Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection